ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,131Medicare Part D Prescriptions Filled, Including Refills

Rank: 161 out of 890

$567K Total Retail Price of All Prescriptions

Rank: 212 out of 890

471 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 471 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

22% of this provider’s 471 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 8,387 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LISINOPRIL 432 279 1 4
HYDROCODONE-ACETAMINOPHEN 379 219 S3 2 3
AMLODIPINE BESYLATE 348 276 3 1
HYDROCHLOROTHIAZIDE 323 216 4 9
FUROSEMIDE 321 267 5 7
GLIMEPIRIDE 295 181 6 27
SIMVASTATIN 288 224 7 5
OMEPRAZOLE 285 239 8 8
METOPROLOL TARTRATE 268 190 9 15
METFORMIN HCL 265 175 10 6
PRAVASTATIN SODIUM 251 189 11 10
GABAPENTIN 251 141 11 12
ATENOLOL 217 120 13 23
WARFARIN SODIUM 198 178 14 24
ZOLPIDEM TARTRATE 194 125 15 19
LOVASTATIN 184 116 16 46
LEVOTHYROXINE SODIUM 177 148 17 2
PREDNISONE 160 117 18 47
MELOXICAM 154 108 19 18
ATORVASTATIN CALCIUM 147 109 20 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 135 103 21 21
CARVEDILOL 133 115 22 22
ISOSORBIDE MONONITRATE ER 132 93 23 60
AZITHROMYCIN 127 87 24 37
NEXIUM 125 78 25 14
POTASSIUM CHLORIDE 125 99 25 11
CLOPIDOGREL 121 106 27 28
TRAMADOL HCL 120 94 28 16
LOSARTAN POTASSIUM 117 90 29 29
DONEPEZIL HCL 112 112 30 30
CITALOPRAM HBR 111 69 31 20
DIOVAN 98 84 32 33
PANTOPRAZOLE SODIUM 96 70 33 34
METOPROLOL SUCCINATE 88 74 34 17
PLAVIX 85 70 35 42
DIGOXIN 82 64 36 65
DOXAZOSIN MESYLATE 81 61 37 70
CARISOPRODOL 79 15 R 38 69
LYRICA 73 31 39 71
LANTUS 72 30 40 50
NAMENDA 72 72 40 36
ALLOPURINOL 67 42 42 31
SINGULAIR 66 50 43 79
DICLOFENAC SODIUM 65 35 44 96
CRESTOR 63 57 45 25
FLUOXETINE HCL 63 27 45 63
PROAIR HFA 62 49 47 55
ENALAPRIL MALEATE 62 27 47 56
TIZANIDINE HCL 59 36 49 106
BISOPROLOL FUMARATE 57 46 50 163
TAMSULOSIN HCL 56 49 51 32
JANUVIA 54 27 52 59
COMBIVENT 54 42 52 144
CLONIDINE HCL 54 27 52 35
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 33 55 76
METOCLOPRAMIDE HCL 53 25 55 125
AGGRENOX 50 38 57 219
PHENYTOIN SODIUM EXTENDED 50 27 57 111
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 11, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.